Filtros de búsqueda

Lista de obras de

5α-Reductase Inhibitors for Prostate-Cancer Prevention ⬇️

artículo científico publicado el 15 de diciembre de 2011

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

artículo científico publicado en 2020

A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases

artículo científico publicado en 2003

A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer

scientific article published on 15 January 2020

A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer

scientific article published on 24 January 2020

A new therapy paradigm for prostate cancer founded on clinical observations

artículo científico publicado en 2010

A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells

artículo científico publicado en 2007

Aberrant expression of katanin p60 in prostate cancer bone metastasis ⬇️

artículo científico publicado el 16 de junio de 2011

Abiraterone acetate

artículo científico publicado en 2011

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study ⬇️

artículo científico publicado el 18 de septiembre de 2012

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3

artículo científico publicado en 2015

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial

artículo científico publicado en 2013

Abiraterone and increased survival in metastatic prostate cancer

artículo científico publicado en 2011

Abiraterone in metastatic prostate cancer without previous chemotherapy

artículo científico publicado en 2013

Abstract 2780: Xenografts of human prostate cancer - a genetic profile analysis

Abstract 3747: Radium 223 inhibits prostate cancer in bone via zonal cytotoxicity

scholarly article

Abstract 385: MTAP gene deficiency creates vulnerability to anti-folate therapy in urothelial bladder carcinoma

scholarly article

Abstract 446: Plasma genome sequencing identifies prostate cancer patients that are sensitive to platinum-based therapy

scholarly article

Abstract 448: Genomic instability as a marker of poor prognosis in advanced prostate cancer: Subclonal insights from whole-genome sequencing of single circulating tumor cells

scholarly article

Abstract 4674: Targeting cancer stem-cells in aggressive variant prostate cancers

scholarly article

Abstract A03: Analyses of a prostate cancer patient-derived xenografts series, a resource for translational research

Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens

artículo científico publicado en 2007

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data

artículo científico publicado en 2007

Adipose tissue-derived stem cells promote prostate tumor growth

artículo científico publicado en 2010

Aggressive variants of castration-resistant prostate cancer

artículo científico publicado en 2014

Androgen Regulation of 5α-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention ⬇️

artículo científico publicado el 14 de diciembre de 2011

Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer

artículo científico publicado en 2017

Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients

artículo científico publicado en 2004

Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms

artículo científico publicado en 2008

Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues

scholarly article

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

artículo científico publicado en 2018

Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies

artículo científico publicado en 2021

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoring

artículo científico publicado en 2007

Beyond comparing means: the usefulness of analyzing interindividual variation in gene expression for identifying genes associated with cancer development

artículo científico publicado en 2012

Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer

artículo científico publicado en 2008

Bortezomib as a potential treatment for prostate cancer

artículo científico publicado en 2004

Building a statistical model for predicting cancer genes

artículo científico publicado en 2012

CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients

artículo científico publicado en 2008

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial

scientific article published on 09 September 2019

Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial ⬇️

artículo científico publicado el 19 de noviembre de 2012

Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.

artículo científico publicado en 2014

Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.

artículo científico publicado en 2010

Cadherin-11 promotes the metastasis of prostate cancer cells to bone

artículo científico publicado en 2008

Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data

artículo científico publicado en 2009

Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer

artículo científico publicado en 2016

Chemotherapy for advanced prostate cancer: 25 years later

artículo científico publicado en 2008

Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma

artículo científico publicado en 2002

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone

scientific article published on 06 June 2019

Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potential

scientific article published on 01 October 2004

Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy.

artículo científico publicado en 2017

Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer

artículo científico publicado en 2004

Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways

artículo científico publicado en 2012

Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers

artículo científico publicado en 2015

Combined laser capture microdissection and serial analysis of gene expression from human tissue samples

artículo científico publicado en 2005

Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel

artículo científico publicado en 2020

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies

scientific article published on 13 September 2018

Current and emerging treatment modalities for metastatic castration‐resistant prostate cancer ⬇️

artículo científico publicado el 1 de abril de 2011

Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer

artículo científico publicado en 2005

Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study

artículo científico publicado en 2011

Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation

artículo científico publicado en 2009

Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing

artículo científico publicado en 2020

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

artículo científico publicado en 2009

Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts

artículo científico publicado en 2003

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

artículo científico publicado en 2013

ER stress in prostate cancer: A therapeutically exploitable vulnerability?

artículo científico publicado en 2018

Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors

artículo científico publicado en 2004

Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomis

artículo científico publicado el 9 de noviembre de 2012

Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy

artículo científico publicado en 2013

Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone ⬇️

artículo científico publicado el 19 de diciembre de 2011

Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases

artículo científico publicado en 2003

Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group

artículo científico publicado en 2004

Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapies

artículo científico publicado en 2007

Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer

artículo científico publicado en 2017

Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro

scientific article published on 21 January 2019

Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470.

artículo científico publicado en 2002

Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients

scientific article published on 20 April 2019

Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression

scientific article published on 18 December 2019

Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer

artículo científico publicado en 2004

Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling ⬇️

artículo científico publicado el 1 de junio de 2011

Fibroblast growth factors signaling in bone metastasis

scientific article published on 01 May 2020

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors

artículo científico publicado en 2020

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

artículo científico publicado en 2018

Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.

artículo científico publicado en 2007

Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers.

artículo científico publicado en 2018

GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example

artículo científico publicado en 2009

Genes with a large intronic burden show greater evolutionary conservation on the protein level

artículo científico publicado en 2014

Genetic Variants in Epithelial Mesenchymal Transition Genes as Predictors of Clinical Outcomes in Localized Prostate Cancer

artículo científico publicado en 2020

Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort

scientific article published on 29 October 2018

Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC‐0449 in the bone forming prostate cancer xenograft MDA PCa 118b ⬇️

artículo científico publicado el 27 de marzo de 2012

High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer

artículo científico publicado en 2004

Housekeeping genes in prostate tumorigenesis

artículo científico publicado en 2009

How to get the most from microarray data: advice from reverse genomics

artículo científico publicado en 2014

Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer

artículo científico publicado en 2015

Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer

artículo científico publicado en 2015

Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic ⬇️

artículo científico publicado en 2014

Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302.

artículo científico publicado en 2015

Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell

artículo científico publicado en 2006

Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate

artículo científico publicado en 2015

In silico functional profiling of individual prostate cancer tumors: many genes, few functions ⬇️

artículo científico publicado el 1 de mayo de 2012

Increased serum insulin‐like growth factor‐1 levels are associated with prolonged response to dasatinib‐based regimens in metastatic prostate cancer ⬇️

artículo científico publicado el 31 de enero de 2013

Informative clinical investigation: a demanding taskmaster

artículo científico publicado en 2009

Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesis

artículo científico publicado en 2008

Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207

artículo científico publicado en 2002

Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1

artículo científico publicado en 2002

Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer

artículo científico publicado en 2007

Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers ⬇️

artículo científico publicado el 2 de julio de 2012

Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer

artículo científico publicado en 2015

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study

artículo científico publicado en 2014

Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis

artículo científico publicado en 2016

Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer

artículo científico publicado en 2016

Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone

artículo científico publicado en 2018

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

artículo científico publicado en 2014

Is It Time to Re-Examine the Prostate Cancer Treatment Paradigm by Targeting the Interaction Between the Prostate and Metastases?

artículo científico publicado en 2016

Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience

artículo científico publicado en 2004

Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients

artículo científico publicado en 2020

Ligand‐independent activation of MET through IGF‐1/IGF‐1R signaling ⬇️

artículo científico publicado el 17 de abril de 2013

Management of Clinical Stage I Testicular Cancer: How Should We Define Success?

artículo científico publicado en 2015

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

artículo científico publicado en 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

artículo científico publicado en 2017

Maximizing outcomes in genitourinary cancers across the treatment continuum ⬇️

artículo científico publicado el 1 de abril de 2011

Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer.

artículo científico publicado en 2016

Merging microarray data, robust feature selection, and predicting prognosis in prostate cancer.

artículo científico publicado en 2006

Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

artículo científico publicado en 2016

Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options

artículo científico

Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African Americans

scientific article published on 13 August 2019

Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features ⬇️

artículo científico publicado el 12 de diciembre de 2011

Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression

scientific article published on 04 December 2013

Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer

artículo científico publicado en 2014

Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification

artículo científico publicado en 2009

Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer

artículo científico publicado en 2010

Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometry.

artículo científico publicado en 2018

NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells

artículo científico publicado en 2009

Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer

scientific article published on 01 April 2020

Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: morphological, immunohistochemical, and gene expression profiles

artículo científico publicado en 2010

Novel therapies for metastatic castrate-resistant prostate cancer

artículo científico publicado en 2011

Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy

artículo científico publicado en 2005

Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer

scientific article published on 11 March 2019

Osteoblasts in prostate cancer metastasis to bone

artículo científico publicado en 2005

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel

artículo científico publicado en 2018

PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer

artículo científico publicado en 2014

PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era.

artículo científico publicado en 2012

Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell Clusters

artículo científico publicado en 2016

Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype

artículo científico publicado en 2005

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial

artículo científico publicado en 2014

Personalized oncology through integrative high-throughput sequencing: a pilot study

artículo científico publicado en 2011

Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer

artículo científico publicado en 2009

Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer

artículo científico publicado en 2004

Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response ⬇️

artículo científico publicado el 15 de julio de 2011

Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma

artículo científico publicado en 2003

Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer

artículo científico publicado en 2008

Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer

artículo científico publicado en 2002

Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases

artículo científico publicado en 2007

Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer

artículo científico publicado en 2004

Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure.

artículo científico publicado en 2013

Prioritizing genes associated with prostate cancer development ⬇️

artículo científico publicado el 2 de noviembre de 2010

Prostate Cancer: Quo Vadis?

scientific article published on 09 July 2019

Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases

artículo científico publicado en 2014

Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.

artículo científico publicado en 2003

Prostate cancer: combination of vaccine plus ipilimumab--safety and toxicity

article

Prostate cancer: thalidomide for prostate cancer: is there progress?

artículo científico publicado en 2009

Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features

artículo científico publicado en 2002

Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results

artículo científico publicado en 2015

Radiotherapy for metastatic prostate cancer

Radium 223-Mediated Zonal Cytotoxicity of Prostate Cancer in Bone

scientific article published on 01 October 2019

Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer

artículo científico publicado en 2014

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.

artículo científico publicado en 2016

Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancer

artículo científico publicado en 2003

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

artículo científico publicado en 2003

Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium ⬇️

artículo científico publicado el 1 de abril de 2010

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

article by Mieke Van Hemelrijck et al published March 2019 in European Urology

Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells

artículo científico publicado en 2003

Reply to J.B. Aragon-Ching and D. Dalela et al

scientific article published on 12 December 2016

Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer

artículo científico publicado en 2020

Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate

artículo científico publicado en 2002

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.

artículo científico publicado en 2017

Single-cell circulating tumor cell analysis reveals genomic instability as a distinctive feature of aggressive prostate cancer

scientific article published on 27 April 2020

Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer

artículo científico publicado en 2008

Stem-cell origin of metastasis and heterogeneity in solid tumours

artículo científico publicado en 2002

Survival outcomes in patients receiving immune checkpoint inhibitor (ICI) for metastatic small cell urothelial cancer (SCUC).

artículo científico publicado en 2021

Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer

artículo científico publicado en 2018

TAD: a web interface and database for tissue microarrays.

artículo científico publicado en 2002

Targeting Constitutively Activated β1 Integrins Inhibits Prostate Cancer Metastasis ⬇️

artículo científico publicado el 21 de enero de 2013

Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer

artículo científico publicado en 2016

Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.

artículo científico publicado en 2006

Targeting prostate cancer bone metastases

artículo científico publicado en 2003

Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer

artículo científico publicado en 2017

Technology-enabled longitudinal monitoring of patient-reported outcomes (PROs) to individualize care of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ICIs).

artículo científico publicado en 2020

Thalidomide/estramustine/paclitaxel in metastatic androgen-independent prostate cancer

artículo científico publicado en 2006

The Association of Peri-Prostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance

scientific article published on 27 July 2020

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

artículo científico publicado en 2020

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The MD Anderson prostate cancer patient-derived xenograft series (MDA PCa PDX) captures the molecular landscape of prostate cancer and facilitates marker-driven therapy development

artículo científico publicado en 2020

The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer

artículo científico publicado en 2002

The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study

artículo científico publicado en 2016

The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials ⬇️

artículo científico publicado el 28 de octubre de 2011

Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy

artículo científico publicado en 2005

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

artículo científico publicado en 2021

Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II study

artículo científico publicado en 2003

Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP).

artículo científico publicado en 2003

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

artículo científico publicado en 2016

Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes ⬇️

artículo científico publicado el 1 de noviembre de 2011

Understanding the biology of bone metastases: key to the effective treatment of prostate cancer

artículo científico publicado en 2008

Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).

artículo científico publicado en 2014

Variant prostate carcinoma and elevated serum CA-125.

artículo científico publicado en 2014

Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis

scientific article published on 01 February 2019

p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells

artículo científico publicado en 2002

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda